UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said. The fine, levied by the ...

I've already discussed Astra's results this week. Here's why Glaxo looks by far the better bet. If you didn't bother delving into the results, you might wonder what the grounds for optimism are.

The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years ...

The Post has sought comment from Pfizer. Zantac was brought to market in 1983 by Glaxo Holdings, a company that is now part ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

View all information regarding the medicines that are manufactured by Glaxo Smithkline Pharmaceuticals Ltd. including its generic drug name, trade name, how to use, the price, and its composition.

What is the share price of Glaxosmithkline Pharmaceuticals Ltd (GLAXO) today on NSE? As on Jan 23, 2025, Glaxosmithkline Pharmaceuticals Ltd (GLAXO)’s share price on NSE is Rs 2090.5 What is the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Learn about Glaxo Smithkline Pharmaceuticals Ltd in Thane, Maharashtra.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...